Discover
NXTC
NextCure, Inc.
5.84
1 x 6.40
1 x 6.50
bid
ask
+
0.25
4.47%
41 @ 04:00 PM
6.40 +0.56 (9.59%)
| Ytd | -58.84% | |
| 1y | 14.73% |
5.15
day range
5.91
1.60
52 week range
14.27
| Open | 5.27 | Prev Close | 5.59 | Low | 5.15 | High | 5.91 | Mkt Cap | 21.09M |
| Vol | 271.06K | Avg Vol | 2.24M | EPS | -17.19 | P/E | -0.34 | Forward P/E | -0.66 |
| Beta | 0.79 | Short Ratio | 1.89 | Inst. Own | 57.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 3.70 | 200-d Avg | 9.49 | 1yr Est | 3.33 |
| Income Statement | |||
| Operating Expenses | 10.11M | ||
| Research and Development Expense | 6.83M | ||
| Selling, General and Administrative Expense | 3.27M | ||
| Operating Income | -10.10M | ||
| Net Income | -9.80M | ||
| Net Income Common Stock | -9.80M | ||
| Net Income Common Stock (USD) | -9.80M | ||
| Consolidated Income | -9.80M | ||
| Earnings per Basic Share | -1.87 | ||
| Earnings per Basic Share (USD) | -1.87 | ||
| Earnings per Diluted Share | -1.87 | ||
| Earning Before Interest & Taxes (EBIT) | -9.80M | ||
| Earning Before Interest & Taxes (USD) | -9.80M | ||
| Weighted Average Shares | 5.24M | ||
| Weighted Average Shares Diluted | 5.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 15.17M | ||
| Cash and Equivalents (USD) | 15.17M | ||
| Investments | 14.58M | ||
| Investments Current | 14.58M | ||
| Current Assets | 31.74M | ||
| Property, Plant & Equipment Net | 5.39M | ||
| Total Assets | 37.98M | ||
| Total Debt | 3.88M | ||
| Current Liabilities | 6.89M | ||
| Debt Non-Current | 3.88M | ||
| Total Liabilities | 11.26M | ||
| Accumulated Retained Earnings (Deficit) | -445.78M | ||
| Accumulated Other Comprehensive Income | -2.00K | ||
| Shareholders Equity | 26.72M | ||
| Shareholders Equity (USD) | 26.72M | ||
| Assets Non-Current | 6.24M | ||
| Total Debt (USD) | 3.88M | ||
| Liabilities Non-Current | 4.37M | ||
| Trade and Non-Trade Payables | 3.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 437.00K | ||
| Net Cash Flow from Financing | 1.25M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.81M | ||
| Issuance (Purchase) of Equity Shares | 1.25M | ||
| Net Cash Flow from Investing | 1.30M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.30M | ||
| Net Cash Flow from Operations | -13.36M | ||
| Share Based Compensation | 344.00K | ||